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SUMMARY
A final report is presented for Spacelab-3 (SL-3) Shuttle experiment,
#3AFT23. Four male astronauts participated as subjects in this experiment.
CrewmembersA and B served as treatment subjects (i.e., received preflight training
for control of their own motion sickness symptoms} and CrewmembersC and D served as
controls (i.e., did not receive training). A preliminary evaluation of Autogenic-
FeedbackTraining (AFT) was madefrom visual inspections of graphs that were
generated from the preflight and inflight physiological data which included:
I. Baseline rotating-chair Zests for all crewmembers.
2. Posttraining rotating-chair tests of treatment group subjects.
3. Preflight data from joint integrated simulations (JIS) for all crewmembers.
4. Flight data for all crewmembersduring mission days O through 4 and mission
day 6 for treatment subjects only.
A summaryof the conclusions based on these data is outlined in the following
sections. The preflight training schedule given to treatment group subjects was, on
average, 90 days longer than planned because of delays in the ]aunch date. This
change in the schedule and its effect on training performance was discussed in two
earlier reports (SL-3 Flight Readiness Review, April 25, 1985 and the SL-3 30-Day
Report, June 12, 1985). The investigators concluded that the generally poorer per-
formance of crewmembersin this study was primarily due to the change in the sched-
ule, although motivation mayhave been a secondary factor. The data of crewmembersA
and B were compared to the data of 40 test subjects who were given AFTusing a more
optimal schedule in the laboratory. The increase in the numberof rotations toler-
ated from the pre- to posttraining rotating-chair tests was computed for all sub-
jects and their scores were ranked from the largest to smallest increase.
CrewmemberA showedan increase of 398 rotations and his score amongthe sample of
42 subjects was about average, at the 54th percentile. CrewmemberB, however, showed
muchless improvement in motion sickness tolerance after training, with an increase
of only 102 rotations. His score amongthe larger sample of subjects was at the 18th
percentile.
Each crewmember's initial susceptibility to motion sickness, (i.e., number of
rotations tolerated before reaching severe malaise), was recorded during their
baseline rotating-chair test. The physiological responses of treatment subjects
which changed the most during motion-sickness stimulation from their resting base-
line levels were selected as training measures for subsequent AFTsessions.
Both CrewmembersA and B were each given 12 preflight AFTsessions without
rotation in which they were taught to increase and decrease, on alternate trials,
their heart rate (HR), skin conductance (SC), and finger pulse volume (FPV) with the
aid of visual and auditory feedback. These subjects were also instructed to use the
feedback from the three different responses to change a pattern (i.e., HRand SCup,
FPVdownor HRand SCdown, FPVup) without changing respiration rate or muscle
activity. An exampleof the physiological data from one training session is included
in this report.
The physiological data of CrewmemberA collected during the pretraining
rotating-chair test was compared to the data from his posttraining rotating chair
test. A visual inspection of the data for this subject showeda reduction in sympa-
thetic tone (i.e., decreased stress} for all three physiological responses in his
posttraining test. Further, while this crewmembermaintained lower physiological
levels, he was able to tolerate muchhigher rotational velocities than during his
pretraining test. Whenthe pre- and posttraining rotating-chair tests of Crew-
memberB were compared, there was somereduction in heart rate after training,
whereas skin conductance and finger-pulse volume still showeda stress response and
motion sickness tolerance increased only slightly.
On the basis of their preflight training and motion-sickness-test data, the
investigators predicted (meeting minutes documented in the SL-3 Flight Readiness
Review, April 25, 1985) that CrewmemberA would have a higher probability of success
at preventing or controlling his symptomsin space than CrewmemberB.
The inflight symptomreports revealed that crewmemberA did not experience any
severe-symptomepisodes during the mission, whereas crewmemberB reported one
severe-symptomepisode. Both control-group subjects, C and D (who took anti-motion-
sickness medication} reported multiple-symptom episodes on mission day O. Whenthe
inflight physiological data of crewmemberA were compared to those of the other
crewmembersparticipating in this study, he showedreduced sympathetic tone for all
physiological variables measured.
The following recommendations were madeby the investigators for future
flights. (I) Usea better preflight training schedule for treatment subjects that
would begin at 10 months to I yr prior to launch with "follow-up" AFTsessions at
launch minus 3 months. (2) Reduce inflight requirements for physiological monitoring
to the first three mission days only. (3) Modify flight hardware to facilitate crew
mobility and comfort.
The preliminary results from this Spacelab-3 experiment are encouraging. The
measurementsand inflight procedures that were used should eventually enable the
investigators to evaluate AFTas a countermeasure for space adaptation syndrome
(SAS), and to objectively document humanpsychophysiological responses to the micro-
gravity environment. However, it is clear that additional data must be obtained
inflight (i.e., eight treatment group subjects and eight control group subjects)
before these goals can be achieved.
INTRODUCTION
Space Adaptation Syndrome(SAS) is a motion sickness-like disorder which
affects up to 50%of all people exposed to microgravity in space. Autogenic-
feedback training (AFT) is a physiological conditioning procedure which can be used
to reduce motion sickness symptomsas an alternative to pharmacological manage-
ment. The Spacelab-3 mission was the first in a series of shuttle flight tests of
AFT. Detailed descriptions of both preflight and inflight procedures for Spacelab-3
experiment, #3AFT23,are presented here. Data obtained are given in graphic form.
The research objectives of this experiment were as follows.
I. The first objective was to determine if preflight AFT is an effective
treatment for space motion sickness. Those subjects who received AFT should experi-
ence fewer symptomsinflight than control group subjects who received no treatment
or an alternative treatment.
2. The second objective was to determine if preflight improvements in motion
sickness tolerance can be used to predict crewmemcers'success in controlling symp-
toms inflight. Crewmemberswho demonstrate greater physiological control and are
able to tolerate motion sickness stimulation significantly longer after training
should experience fewer symptomsduring the mission.
3. The third objective was to identify differences and similarities between
the physiological data from preflight motion-sickness tests and data collected
during observed symptomepisodes in space.
METHODS
Subjects
Four men (ages 42 to 60) participated in this experiment as Spacelab-3 cre_em-
bers. There were two control group subjects and two treatment group subjects. Two
backup crewmembers,ages 34 to 38, also served as treatment group subjects and
participated in all preflight activities. The preflight data of backup crewmembers
are included in Appendix A. All subjects were medically certified (class I flight
physical) to serve as crewmembersaboard Space Shuttle Missions.
Apparatus
Flight Hardware And Measures- An ambulatory monitoring system was used to
record the autonomic responses of crewmembers in space and provide real-time feed-
back of physiological information. This system (see Appendix B), is made up essen-
tially of four major components: (I) the Biosuit, a customized undergarment
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designed for attachment of respiration transducers and cabling; (2) a cable harness,
consisting of electrode and transducer wiring which mounts to the biosuit with
velcro ties and interfaces with (3)and (4); (3) the Autogenic Feedback System (AFS),
a portable instrument mounted on a crewmember's belt which contains analog and
digital electronics as well as an 8-track, digital, cassette tape recorder; and (2)
a wrist-worn digital display used to control the mode of operation of the AFS and
provide physiological information (feedback) to trained crewmembers. The AFS was
also used to monitor physiological responses during preflight baseline testing,
training sessions, and Joint integrated simulations. Physiological measures recorded
with the AFS included the following.
I. The electrocardiogram (ECG) was derived from precordial placement of
silver-silver chloride disposable electrodes.
2. The respiratory wave form was derived from two piezoelectric transducers
mounted over the chest and abdomen. Only relative changes in compartmental volume
were measured.
3. The basal skin resistance (BSR) was derived from two silver-silver chloride
disposable electrodes mounted on the volar surface of the left wrist.
4. The finger pulse volume (FPV) was measured with a photoplethysmograph
transducer mounted on the volar surface of the little finger on the left hand.
Changes in the peak-to-peak amplitude of the waveform were monitored to obtain a
relative measure of peripheral vasomotor activity.
5. The skin temperature (ST) was measured on the little finger on the left
hand using a semiconductor transducer. Both the photoplethysmograph (FPV) and tem-
perature transducers were mounted in a rubber ring which was attached to the finger
with tape.
The AFS also included electronics for measuring X-, Y-, and Z-axis accelera-
tions. A 5-g accelerometer was mounted to a lightweight headset, which was part of
the crewmember's standard equipment. These measurements, taken only during the
flight, were used to evaluate the relationship between motions of the head and
symptom onset.
Training Hardware and Measures- The physiological measures described below were
also recorded during preflight baseline and AFT sessions.
I. Heart rate (HR) was measured w_th a biotachometer which detected R-peak to
R-peak intervals from the ECG signal.
2. Respiration rate (RR) was measured with a biotachometer which detected zero
crossings from the respiratory wave form.
3. Skin conductance level (SCL) was measured with silver-silver chloride
electrodes mounted on the index and middle finger of the left hand, using a J & J
Enterprises, model #M-68 amplifier.
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4. Skin temperature (ST) wasmeasuredwith two thermistors mounted on the
index fingers of the left and right hands using a J & J Enterprises model #M-68
amplifier.
5. Electromyography (EMG)of the left and right forearm extensor muscles was
derived from three silver-silver chloride disposable electrodes using a J & J Enter-
prises, model #M-58 amplifier.
6. Finger pulse volume (FPV) was measuredwith a photoplethysmograph trans-
ducer mountedon the right index finger using an L & M Electronics model #101
amplifier.
Biomedical amplifiers and the AFSwere mounted on the rear of a rotating chair
and the physiological signals were sent through slip rings to laboratory equipment.
These signals were recorded on strip charts and on a 14-track FManalog tape, and
were digitized in real time with a LSI-11 computer. A special playcack system was to
be used to transfer the flight data from digital cassette tape to J-track magnetic
tape. However, the system was never provided to the investigators, instead, an
alternate playback system provided by Johnson Space Center was usec to reduce flight
and JIS data. This process involved converting digital data to analog tape and then
reproduced the data on strip-chart recorders. The accuracy of Shedata contained in
this report was confirmed by inspection of hardcopy waveforms° _ DECPDP11/34
computer was used for data reduction.
During formal AFTsessions (see Procedure, Section B. Autonomic Conditioning/
Testing), visual feedback of the crewmember'sphysiological responses was displayed
on a wide-screen oscilloscope and on eight digital panel meters. Verbal instructions
from the experimenter were delivered to subjects by an intercommunication system.
Auditory feedback tones were provided by two speakers mountedabove the subject's
head.
Preflight motion-sickness tests
I. A Stille-Werner rotating chair was used to provoke the symptomsof motion
sickness. Paddedhead rests were mountedat 45° angles from the vertical position on
the left, right, front, and back of the chair which enabled the subjects to execute
head movementsin these directions.
2. A second motion-sickness test was conducted in the Vertical Acceleration
and Roll Device (VARD). The VARDis a light-proof enclosed cab. Vertical motion of
the cab was maintained at a constant frequency. Subjects were monitored by closed-
circuit video and by an intercommunication system during the test.
PROCEDURE
Preflight Crew Participation Requirements
Baseline Motion Sickness Tests- The initial symptoms of motion sickness were
induced in the rotating chair. Physiological responses were monitored and the indi-
vidual's symptoms were documented using a standard diagnostic rating scale (refer to
Appendix C for an explanation of the scoring procedure). Subjects were blindfolded
during rotating chair tests. Rotation of the chair was initiated at 6 rpm
(0.628 rad/sec) with 2-rpm (0.209 rad/sec) increments every 5 min. The maximum
velocity was 30 rpm (3.142 rad/sec). During each 5-min interval at a constant
rotational velocity, subjects executed 150 head movements at 45 ° angles in four
quadrants. Instructions for making head movements at 2-sec intervals were delivered
to subjects by a tape-recorded voice. The direction of head movements was random-
ized. There was a 30-sec pause between each 5-min period (no head movements but
continued rotation) during which time the diagnostic scale was administered. Tests
were terminated at 30 rpm or malaise level Ill (Appendix C).
Motion sickness symptoms were also induced using the VARD. Physiological
responses were monitored and the individual's symptoms documented. The VARD tests
were conducted by maintaining vertical motions of the cab at 0.33 Hz and 0.35 g,
with a maximum displacement of ±2.5 ft. Subjects were instructed to make head move-
ments in four quadrants at 2-sec intervals. Diagnostic symptom reports were taken at
5-min intervals. The VARD tests were terminated after 75 min of motion or malaise
level Ill was reached (Appendix C).
Resting baseline sessions were conducted in a reclining chair within a dark-
ened, quiet chamber while the subject listened to tape-recorded music for a period
of 30 min on two consecutive days. His physiological responses were monitored and
these data were then compared to motion-sickness test data for establishing an
individual "stress profile." Emphasis in subsequent AFT sessions was placed on those
autonomic responses which showed large magnitude changes from the subject's resting
baseline levels.
Autonomic Conditioning/Testing- Four crewmembers (two prime and two backup)
were trained to control their autonomic responses during 12 AFT sessions. Each
30-min training session was divided into 3-min trials during which crewmembers were
taught to produce alternating increases and decreases in physiological activity
levels. These 12 sessions were distributed over a 7-month period (launch minus
8 months to launch minus I month). Launch delays forced a modification of the
planned training schedule which was to have been a 3-month period (launch minus
4 months to launch minus I month).
Three rotating-chair tests were given to each crewmember to evaluate changes in
motion-sickness tolerance following 2, 4, and 6 hr of AFT.
Inflight Crew Participation Requirements
Appendix B is the Payload Flight Data File Book (PFDFB)from SL-3. The FDFB
describes in detail the AFTprocedures performed by both treatment and control
subjects. These procedures are outlined below.
Continuous Physiological Monitoring- All crewmembers who participated in this
experiment were required to wear the ambulatory monitoring system continuously
during waking hours (approximately 12 hr), on mission days O through 4. This
requirement involved the following activities.
I. During the postsleep activity period on each mission _ay, the crewmember
donned the ambulatory monitoring system and initiated data recording. The cassette
tape was replaced daily after 7 hr of operation. A spare tape and a diagnostic lo_
book for recording symptoms were kept in a belt-worn pouch containing the AFS.
2. Battery packs were replaced on alternate mission days.
3. Electrodes and/or transducers were replaced on an as-needed basis, using
spares from the stowage locker.
4. The biosuit, AFS, cassette tapes, and diagnostic log book were removed ant
restowed during the pre-sleep activity period.
Time-Lined and Symptom-Contingent Diagnostic Scale Reports- All crewmembers who
participated in this experiment were required to keep a written log of their symp-
toms using the diagnostic rating scale at specific times twice daily (i.e., time-
lined). If symptoms occurred at any time during the mission, crewmembers were again
required to administer the diagnostic scale (i.e., the scale was
symptom-contingent).
Time-Lined and Symptom-Contingent Autogenic Feedback Training (Treatment
Subjects Only)- Immediately following the first, daily, time-lined diagnostic scale.
treatment group subjects were instructed to practice AFT for a 15-min period with
the aid of the wrist-worn feedback displays. No other flight activity occurred
during this period. If a symptom episode occurred, the crewmember was again required
to apply AFT to counteract his symptoms. This activity was not to exceed 30 min, and
the crewmember could continue any scheduled mission activities during this period.
The crewmember was required to administer the diagnostic scale immediately following
this AFT session.
Postflight Crew Participation Requirements
All crewmembers who participated in this experiment were required to attend a
2-hr debriefing session within 14 days postflight.
RESULTS
Baseline Data Collection
Resting Baseline- Table I is a summary of the preflight resting baseline data
for each subject. Means and standard deviations were computed for each physiological
variable from 60 1-min averages which were collected during two 30-min sessions.
Each crewmember's physiological data from JIS and the flight were transformed to
z-scores. Graphs of the z-score values (figs. 13-39) show changes in the physiologi-
cal activity levels that are relative to each crewmember's resting baseline means
and standard deviations (SD).
TABLE I.- RESTING BASELINE DATA MEANS AND STANDARD DEVIATIONS OF EACH
PHYSIOLOGICAL RESPONSE
Crewmember
Finger pulse
volume,
units/min
3.3
2.6
14.1
5.8
9.7
4.4
23.9
6.8
Respiration
rate,
breaths/min
17.1
1.5
10.4
1.6
14.3
1.6
17.1
1.5
Heart
rate,
beats/min
74.3
2.8
78.6
2.1
60.9
1.8
51.3
1.6
Basal skin ! Finger
resistance, I temperature,
log kohm i 'FI
i
i
4.605 92.6
0.075 i 0.7
I
I
I
5.0O2 _ 93.5
I
0.007 ! 0.6
i
i
5.166 _ 93.o
0.040 f 0.8
I
5.532
0.043
81.6
1.1
Mean
SD a
Mean
SD
I Mean
L SD
,
i Mean
I SD
aSD = Standard Deviation
Baseline Motion Sickness Test- The physiological data of each crewmember
recorded during his/her initial rotating-chair test are shown in figures I-4. The
four physiological variables selected for these graphs were similar to those mea-
sures recorded during the flight with two exceptions. Skin conductance level (SCL),
the reciprocal of BSR, was plotted and hand temperature was substituted for FPV
because the flight transducers and electronics were not functional when baseline
motion-sickness tests were conducted.
The X-axes on these graphs were divided into three segments: baseline, min-
utes I through 10 which preceded the start of rotation; test minutes, the time
during actual rotation which varied for each subject; and baseline, 10 min immedi-
ately following the end of chair rotation.
o//
/
/
< o
Z
£
I-
<
E
w
I,..-
f
1 l I I ' ' r I I I
•ulw 'SHlV::I El8
_,[.
t_
I1.1
t'r"
I--
t_
II
w o
<
j
" %1.1.1 i.-
i I _ z r z r 1 r I 1.i
•u,w '$1V38
w
I--
<
t'_
IJJ
w
I--
Z
v
L
¢.t'}
w
rr"
I--
t,,t3
II
,,7
I I I I I I I
E,
9o "93C]
w
._1
w
<
I..¢1 _
_ w
= I--
0
_ I---
i- "J _
w
m rt" O
.J
w
,-- <
' r T e¢_
rr
< _ _
o 2
=: 0
_ _ el:: -
t.f)
[ I I I I I I I I I I0,
$OH_OEIOII/_
u.I
Z
w
<
Z
I--
P
_ w
z
_.1
w
,-- <
E
co
,,
co
I
bo
c-.
o
!,,.,
.,....
!
d
.,'4
r,.
10
LIJ
}-.
<
Z
O
t-
<
t't"
¢t
LU
n-.
O9
uJ
t-
II
i., 1 1
e_
ey
>
}
f
'ul_ 'SH.LV3 EIB
i,-
n.,
i-
uJ
p-
¢D
II
ud
r¢
,,<,
"1-
t I I
£O
I
L___
I.
i-
n"
_<_
I I I I t I I I.
•utuu 'SJ.V38
LU
cr
t-
<
rt"
UJ
t_
iii
Z
LLJ
cJ
F-
E_
Z
O
_J
Z
v
W
r_
II
<
\
I I I I
i-
ll
I I '
0
\.
Z
0
t--
' ' I I I I I
=1o "D30
\
E
_, _ -
I I I I I T
OW
"-Z
_J
_en
Z
I--
_Z
1
UJ
,-<
en
"-Z
.-I
I,M
<
I-"
Z
I.-
_Z
._1
6
L
c'l
E
E
°o
.,..._
t-
I
t'-"
0
c"
.,...i
I
t_
. ,...i
r,.
11
LLI
t--
,'t"
Z
O
I--
LU
rr"
LU
n..
I-
n,-
,¢
I,,U
"I-
U3
I I I I I I I
t,,.=.
•u!tu 'SHI'v'31=1{3
I-
I-
I I J,
LO
U,,I
I Z
/
I I I I _ I I t
uo I_
•uaw 'S2V38
n,-
i,-
I,
w
t"r"
D
I--
,=¢
W
0,.
UJ
Z
v
¢./3
W
(.3
Z
,,¢
I-
Z
O
Z
t.,,'3
I
0'3
03
(
)
\
O
(/3
U.,I
n"
¢/3
II
I I _ f r I
O
_o'030
0"_ "
n-
C.O
II
I I I I I
SOHINOUOI_
r i
I I
LU
Z
--1
LLI
03
,<
m
E w
Z I- _ D
O Z
o
> w
w I--
Z
-J
m
i i,i "-
E
Z
0
.J
o
>
w
ee"
Z
-J
W
W
"D
Z
W
I.-
I--
,,¢0{D _I-
t,_
LLI
Z
I,D UJ
0'3
,¢
rn
I J.
CO
L,
.D
3:
£.,
.°
4-)
, ,..._
_C::
O
I
bO
.,-I
4.3
0
,-4
b3
_U
_3
I
=r
(D
r,.
12
Autonomic Conditioning/Testing
Sample of Autogenic Feedback Training Session- Following each AFT session, each
subject was shown a graph of his physiological data, which was used by the investi-
gators to review the subject's training progress. During laboratory sessions, a
multicolor graph of all physiological responses was produced, but for this report,
only four physiological variables were plotted. Figure 5 represents data from a
crewmember's fifth AFT session. Each session was preceded and followed by a baseline
period of 6 min. The training period was for 30 min and was divided into 10 3-min
trials. These data were plotted as z-scores based on the means and standard devi-
ations of the 6-min presession baseline for each variable. Subjects were instructed
to either increase (arousal) or decrease (relax) their physiological response(s) on
alternate trials with the aid of visual and auditory feedback displays. Subjects
were also instructed to use the feedback from the three different responses to
change a pattern (i.e., HR and SC up, FPV down or HR and SC down, FPV up) without
changing respiration rate or muscle activity.
The bidirectional training approach served two purposes. (I) By cnanging
his/her responses in both directions, the subject learns to discriminate or "recog-
nize" _hysical sensations associated with these changes. (2) With practice, the
subject eventually learns to make the correct pattern of physiological responses
which enables him to control his motion sickness symptoms. A critical step in this
training process involves transfer of learned physiological control from the sta-
tionary AFT sessions to the rotating-chair tests that induced motion sickness.
Increased Motion Sickness Tolerance with Autogenic Feedback Training
Crewmember A- The primary criterion for evaluating the effectiveness of AFT is
increased motion-sickness tolerance after 2, 4, and 6 hr of training. Figure 6 shows
the number of rotations tolerated by Crewmember A during all preflight rotating-
chair zests. Figure 7 shows the physiological response levels produced by this
crewmember during his pretraining and posttraining rotating-chair tests. These data
were plotted as z-scores based on the means and standard deviations of the IO-min
pretest baselines of each variable on both tests. It is clear that this crewmember
achieved better control of his own physiology after all training was complete.
Following AFT, his heart rate and respiration rate were more stable, although it is
unlikely that this change in breathing alone accounted for the stabilizing effect
seen in heart rate. Skin conductance level, a measure of sympathetic tone, showed a
sharp increase (i.e., stress response) at the start of the pretraining rotating
chair test. Following AFT, the overall level of this response is reduced. However,
at 5-min intervals when the rotational velocity of the chair was increased,
Crewmember A initially responded to this stimulus with an increase in skin
conductance, and then brought this response under control. The result was that
average sympathetic tone (as measured by this variable) was reduced. Skin tempera-
ture of the hand, a relative measure of peripheral resistance, is also an index of
sympathetic tone. At the start of the pretraining test, this subject showed a sudden
drop in temperature indicating vasoconstriction, (a typical stress response).
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Following AFT, there was an increase in skin temperature at the start of rotation
which remained stable until just before the termination of the test. Skin-
temperature data also suggest that this subject learned to reduce his sympathetic
tone.
The bargraph (fig. 8) of malaise levels reported by this crewmember was consis-
tent with his physiological data. Following AFT, Crewmember A reported fewer symp-
toms at faster rotational velocities than before training.
Crewmember B- Figure 9 shows the changes in motion sickness tolerance achieved
by Crewmember B across preflight motion-sickness tests. This crewmember showed a
much smaller improvement than Crewmember A. Figure 10 shows that although some
control of heart rate was demonstrated in his posttraining test, no control of
respiration or skin conductance level was observed. Skin temperature increased
toward the middle of the test, but this was associated with an increase in sympa-
thetic tone for all other physiological responses. This increase in stress levels
was associated with an increase in malaise reported (see fig. 11).
Prediction of Inflight Susceptibility to Space Adaptation Synarome
Increases in motion sickness tolerance following preflight AFT was the basis
for predicting a crewmember's success in preventing or controlling his symptoms in
space. In two previous reports (SL-3 Flight Readiness Review, April 25, 1985 and the
SL-3 30-Day Report, June 12, 1985), the investigators reported that training effec-
tiveness for the control of motion sickness symptoms was largely influenced by the
type of schedule administered. Because of delays in the launch date for SL-3, the
training schedule for crewmembers A and B was on average 90 days longer than
planned. The investigators concluded tha_ the generally poorer performance of sub-
jects in this report was primarily due _o changes in the schedule, although motiva-
tion may have been a secondary factor.
The data of crewmembers A and B were compared to the data of 40 test subjects
who were given AFT using a more effective schedule in the laboratory. The increase
in the number of rotations tolerated from the pretraining to posttraining rotating-
chair tests was computed for all subjects and their scores were ranked from largest
to smallest increase. Figure 12 shows a frequency distribution of the ranked scores
of 42 subjects (including crewmembers A and B) which were divided into 10 rotation
intervals. Crewmember A showed an increase of 398 rotations and his score among the
total sample of subjects was about average, at the 5_th percentile. However, Crew-
member B, who showed much less improvement in motion sickness tolerance after train-
ing, with an increase of only 102 rotations ranked at the 18th percentile in this
larger sample of subjects.
On the basis of preflight improvements in motion sickness tolerance of Crew-
members A and B, it was predicted that Crewmember A would have a higher probability
of success in controlling his symptoms in space than Crewmember B. This prediction
was reported at the SL-3 Flight Readiness Review.
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Joint Integrated Simulations
Figures 13-16 show the physiological data of CrewmembersA,B,C, and D. col-
lected during one Joint Integrated Simulation (JIS). Ten-minute averages were gener-
ated from the raw data which were then transformed to z-scores using each crew-
member'spreflight (resting baseline) meansand standard deviations. The X-axis on
the graphs represents mission elapsed time (MET)over a 15-hr period.
The science requirement for JISs involved physiological monitoring for at least
one shift (approximately 8 to 12 hr) for each crewmember. Only CrewmembersA and D
met this requirement; in fact, CrewmemberD provided additional data. CrewmemberC,
however, provided only 6 hr of data and CrewmemberB provided only 2 hr of data.
Thesedata will be used to comparechanges in physiological levels produced
during a 12-hr workday on Earth to those changes observed during a similar period in
space. Preliminary comparisons can be madeby visual inspection of the JiS and
flight-data graphs.
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Inflight Physiological Data
Table 2 is a summary of the results of SL-3, showing each crewmember's pre-
flight susceptibility to motion sickness (number of rotations tolerated); the
increased tolerance of Crewmembers A and B following AFT; and the number of severe
symptom episodes experienced by all crewmembers in s_ace.
TABLE 2.- SUMMARY OF SPACELAB-3 RESULTS
Crewmembers
Controls
C D
46 120
Preflight
motion sickness Treatment
tolerance
(number of rotations) A B
Before training 62 54
After _raining 460 156
Inflight severe
symptom episodes 0 I
aTook anti-motion sickness medication.
4a 2a
The physiological flight data was reduced to 90 10-min averages and then trans-
formed to z-scores using each crewmember's preflight resting baseline means and
standard deviations. These data were further reduced to a daily mean for each physi-
ological variable for each crewmember. Figure 17 compares the daily z-score averages
of physiological data for all crewmembers. The data represented in this figure can
be summarized as follows.
Heart Rate- The average HRs of Treatment Subjects A and B were below their
preflight resting levels, except for mission day O for Crewmember B. During the
preflight motion-sickness tests, heart rate was the only variable which Crewmember B
could reliably control. Crewmember C (control group) showed a higher HR on mission
day O; the rate declined on mission days I and 2 and increased slightly on the last
two mission days. However, Crewmember D (control group) showed elevated HR across
all mission days.
Respiration Rate- The average respiration rate of Crewmember A was below his
preflight resting level for all mission days, except for a slight increase above his
mean on mission day I. Crewmember B's average respiration rate was always higher
than his preflight level. Crewmember C's respiration rate on mission day 0 was
elevated, but was below his preflight mean level on all subsequent mission days.
Crewmember D's average respiration rate was considerably lower than preflight levels
on all mission days.
26
Log Skin Resistance- Only Crewmember A showed skin resistance levels above his
preflight mean across all mission days. Crewmember B showed a large decrease in his
average skin resistance following mission day O. Both Crewmembers C and D (control
group) showed skin resistance_levels below their preflight resting means on all
mission days, with a gradual improvement (toward baseline levels) on the last two
mission days.
Finger Pulse Volume- Only Crewmember A showed average FPV levels higher than
his preflight mean for all mission days. All other crewmem_ers showed finger-pulse-
volume levels lower than than preflight averages. Note that the missing bars for
Crewmember D on mission day I; Crewmember C on mission days 2-4_ and Crewmember B on
mission day 4 indicate loss of data for this variable.
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Mission Days 0-4
Figures 18-39 are graphs of the z-scores of physiological data of all crew-
members collected on mission days 0-4. A maximum of 90 IO-min averages (15 nr) for
each mission day is plotted. Preflight baseline means and standard deviations are
shown on each graph. Crewmembers A and B also participated in data collection during
reentry on mission day 6. Mission elapsed time is represented on the X-axes. The
data collection periods (start and stop MET) for each crewmember were basec on
information written in his flight diagnostic log book. These graphs provide more
detailed information about changes in the physiological levels during each mission
day.
29
Mission Day O- Physiological data were collected for all crewmembers.
Crewmember A: The physiological data associated with launch and approximately
4 hr following orbit insertion were lost for this test subject because of a malfunc-
tioning cable. This crewmember reported moderate malaise during the first 3 hr
following orbit insertion, which he was able to control by using the skills he
learned during preflight training. The data shown here (fig. 18) were recorded
during the Silver Shift (night shift) (MET 10 through 24). kow heart rate, high skin
resistance and finger pulse volume indicated low stress. There were no SAS episodes
reported in this time period. No data were collected during the second half of his
shift because the crewmember reported (in a communication to the Payload Operation
Control Center (POCC)) that he could not locate stowage containers which supported
this experiment. No anti-motion-sickness medication was taken on any mission days.
Crewmember B: Data recording was initiated at approximately 90 min prior to
launch. Crewmember B (fig. 19) shows a high heart rate following ingress into the
orbiter, which began to decrease before the launch. The second peak in heart rate,
which is marked on the X-axis, is associated with launch. The interruption in the
graph shown at MET 2:00 to 2:30 corresponds to the time during middeck reconfigura-
tion. Although this crewmember reported moderate malaise on mission day O, there
were no emetic episodes. Heart rate was below preflight resting levels except for
MET 9 when he reported increased physical exertion that may have accounted for this
observation. Skin resistance levels decreased gradually throughout this shift and
finger pulse volume was below resting levels. No anti-motion-sickness medication was
taken on any mission days.
Crewmember C: Recording was initiated at approximately 90 min prior to launch
and the data reflect similar responses to those seen in Crewmember B (fig. 20)
following ingress and launch. This crewmember reported multiple emetic episodes on
mission day O, the first of which occurred soon after orbit insertion when data
recording was in progress. This crewmember chose not to initate recording for the
remainder of his shift; therefore objective physiological data on the number and
severity of subsequently reported emetic episodes was not obtained. Anti-motion-
sickness medication was taken "more than once" by this crewmember. The actual
dosages and times of medication were not reported during the postflight debriefing.
Crewmember D: Again, data recordings were initiated at launch minus 90 min and
the characteristic ingress and launch levels were observed (fig. 21). When data
recording was recommenced at MET 2, his heart rate level was high, skin resistance
was low and FPV was low. The intermittent loss of data for finger pulse volume was
due to movement artifact. Although more than one emetic episode was reported by this
subject on mission day O, these episodes occurred during MET 1:00 to 1:40 when
physiological-recording hardware was disconnected. The physiological levels that
were observed indicate high stress. However, anti-motion-sickness medication was
taken (actual dosages and times of medication were not reported during the post-
flight debriefing) and may have had an effect on his physiological levels.
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Mission Day I-
Crewmember A: The heart rate of this subject shows two peaks during this 15-hr
period (fig. 22). The first peak in heart rate at MET 16 occurred when the crew-
member left the module to return to the middeck for a meal. There was a sharp
increase in heart rate at MET 19:30, but all other physiological data indicate that
the subject was experiencing low stress. Skin resistance and FPV levels were very
high. No malaise was reported for the remainder of the mission.
Crewmember B: This crewmember reported one emetic episode prior to initiating
data recording (fig. 23). Although his HR was below baseline throughout this shift,
the low skin resistance and FPV data indicate increased sympathetic tone (i.e.,
higher stress levels). The crewmember reported some distress because of a malfunc-
tioning experiment payload and this may be related to observed physiological levels.
Only slight malaise was reported during this shift. No SAS malaise was reported
during the remainder of the mission.
Crewmember C: Heart rate was generally lower than on mission day O (fig. 24).
An increase in heart rate occurred at MET 5:30 when he was scheduled to leave the
module for a meal. Respiration rate was initially low but gradually increased to his
preflight resting level. Skin resistance was low with a graaual decrease during the
shift. Finger-pulse-volume level was low with intermittent peaks around midshift. No
malaise was reported and no anti-motion-sickness medication was taken during this
shift nor for the remainder of the mission.
Crewmember D: The high HR and low skin resistance suggest high sympathetic
tone throughout this shift (fig. 25). Finger-pulse-volume data were lost during this
shift, although the postflight evaluation of hardware showed no malfunction. No
malaise was reported and no anti-motion-sickness medication was taken during this
shift nor for the remainder of the mission.
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Mission DaV 2-
Crewmember A: The low HR, high skin resistance and high FPV suggest that this
crewmember was not experiencing stress (fig. 26).
Crewmember B: Although the HR was low, skin resistance and finger pulse volume
levels were below normal resting levels and therefore indicate high sympathetic tone
(fig. 27). The intermittent loss of data for skin resistance and finger pulse volume
was due to movement artifact. This crewmember did not perform the inflight require-
ment of changing cassette tapes on any mission day following mission day I, which
was not reported to the POCC during the mission. Consequently, only half of the
required data was obtained for this crewmember after mission day I.
Crewmember C: The AFS recorder failed to function for this crewmember at the
beginning of his shift (fig. 28). Data recording using the spare AFS did not occur
until late in the day. During the last 3 hr of his shift, HR was low, respiration
was near his preflight levels, but skin resistance was well below his baseline.
Finger-pulse-volume data were lost. Postflight examination of the finger transcucer
indicated a malfunction. The spare transducer was not used_ consequently no data for
this response were recorded for the rest of the mission.
Crewmember D: The HR levels were high during this shift while respiration rate
was below his preflight baseline level (fig. 29). The SR and FPV data (although
intermittent} were well below baseline levels.
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Mission Day 3-
CrewmemDer A: HR was generally below the baseline level with a peak occurring
at the beginning and close to midshift (fig. 30). Both skin resistance and FPV
remained high, while respiration was low.
Crewmember B: HR gradually declined and then increased to baseline levels at
the end of data recording (midshift) (fig. 31). Respiration rate was high and both
skin resistance and finger pulse volume were lower than preflight resting levels.
Crewmember C: HR was initially high, followed by a decrease at midshift and an
increase at the end of the day (fig. 32). Respiration rate was at or below preflight
resting levels. Skin resistance was initially high and gradually decreased over a
3-hr period and remained at this low level throughout the shift.
Crewmember D: HR levels remained high and respiration rate was low (fig. 33).
Skin resistance showed more fluctuations and was generally higher than on previous
mission days. Finger pulse volume was still below baseline levels.
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Mission Day 4-
Crewmember A: HR and RR were near or below preflight resting levels (fig. 34).
Skin resistance and finger-pulse-volume levels remained high.
Crewmember B: HR showed large fluctuations although the level remained below
baseline (fig. 35). Respiration was higher while skin resistance showed a gradual
decrease during the shift. Finger-pulse-volume data were lost during this shift; a
postflight examination of the transducer showed a malfunction. This crewmember
reported experiencing some gastrointestinal discomfort which was unrelated to SAS.
Crewmember C: HR was initially high with a gradual decrease at midshift and
then an increase during the remainder of the day (fig. 36). Respiration rate showed
large fluctuations at or near the resting level. Skin resistance remained low.
Crewmember D: HR was above his baseline level during the shift, while
respiration rate was low (fig. 37). Skin resistance was initally low with a gradual
increase to baseline at the end of the shift. Finger pulse data were minimal and
below baseline levels. The break in data occurred when this crewmember removed AFT
hardware to perform another payload-related task.
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Mission Day 6 Reentry- No physiological data were collected on any crewmembers
on mission day 5. Data were collected on Crewmembers A and B only on mission day 6
during reentry.
Crewmember A: The sudden peak in HR, rise in RR, and decreases in both skin
resistance and FPV may have occurred during reentry but no MET was recorded
(fig. 38).
Crewmember B: The increase in HR and RR and the decrease in skin resistance
may have occurred during reentry, but no MET was recorded (fig. 39).
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DISCUSSION
Findings to Date
An important finding from this experiment is that Crewmember A, who showed the
best preflight training performance, reported no severe malaise inflight. Further,
all physiological response levels recorded for this crewmember throughout the
mission indicated low sympathetic tone which suggests low stress.
Because continuous physiological monitoring of several parameters during waking
hours had not been previously obtained (by NASA) on humans in space, the investiga-
tors did not really know what to expect. It was possible that the microgravity
environment would produce a lower HR than typically observed on Earth. However,
Crewmember D showed a higher HR on all mission days. Also, the positive fluid shift
that results during exposure to microgravity might have produced lower levels of
FPV. However, Crewmember A, who was successfully trained to regulate blood volume in
his hands, showed consistently higher FPV throughout the mission than all other
crewmembers.
Both Crewmembers C and D reported taking anti-motion-sickness medication on
mission day O, and this may have had an effect on their physiological response
levels. However, despite taking medication, both individuals experienced SAS epi-
sodes on this mission day. In addition, Crewmember D showed elevated heart rate for
all mission days while both crewmembers showed reduced skin resistance and finger
pulse volume throughout the flight. For future flights, it would be very useful to
obtain additional preflight data on the effects of various anti-motion-sickness
drugs and dosages on physiological response levels. These data could then be com-
pared to subsequent flight data for those crewmembers who take medication during the
mission.
Continuous physiological monitoring inflight can be used to answer several
other questions in addition to providing objective information on SAS. For example,
by examining a given crewmember's Payload Crew Activity Plan (PCAP) for each mission
day, the investigators can match the physiological data that is generated to known
crew activities. Given this information, the effects of work load, fatigue, and
disturbances in diurnal cycles on physiological response levels can be determined.
Many data epochs relevant to emetic episodes were lost during this mission
because either the crewmember could not (or would not) wear the flight hardware at
these times or because hardware malfunctioned. The efficacy of AFT as a treatment
for SAS cannot be determined on the basis of data collected on only one mission.
Additional flights will be required to obtain data on a total of 16 subjects. The
investigators have concluded that if the physiological recordings and the other
infligh t requirements of the study are performed by the crew, it will then be pos-
sible to test the hypotheses of this experiment.
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Lessons Learned
Volunteer Crew Participation- During the mission, negative reporting by crew-
members is crucial. Investigators in the POCC should be informed of any failure to
conduct specific payload requirements for any experiment. This procedure requires
cooperation from crewmembers which can only be expected if crew participation in a
given experiment is made on a voluntary basis. Therefore, we highly recommend that
only volunteers be assigned as subjects in the future. Further, the principal
investigator should be given the opportunity to discuss the objectives of the study
and its procedures with the participants at the earliest possible time.
Preflight Schedule and Procedure Changes- The original AFT experiment protocols
written to support STS 51-C and 51-B, defined the crew participation schedule to
include 12 AFT sessions and 3 rotating chair tests conducted from 4 to I months
prior to launch. However, because of launch delays for both missions, these sessions
were distributed over a 7-month period. The result was that these subjects showed
less effective control of their symptoms than subjects who were trained over shorter
periods of time. To eliminate the effect of launch delays on training schedules for
future missions, it is recommended that preflight AFT sessions be administered on
15 consecutive days at I year to 8 months prior to launch. Additionally, a minimum
of 4 and a maximum of 8 AFT followup sessions (during 4 to I months prior to launch}
will be required. The total number of followup sessions needed will be determined on
an individual basis.
Several KC-135 flights have also been added to the protocol during both base-
line and AFT followup sessions for two reasons. (I) One of the concerns of the 51-B
crew was that rotating chair tests (conducted within 4 to I months prior to launch}
produced residual symptoms over a 12-hr period which interfered with other payload
training activities scheduled for the same day. However, KC-135 flights are often
scheduled in this time period to enable crewmembers to practice various payload
activities during microgravity periods. These flight tests have been substituted for
rotating-chair tests, and will be used to assess each crewmember's ability to con-
trol his/her symptoms in this environment. Data from these tests will be used to
determine the number of AFT followup sessions required for each individual. (2) It
is necessary for crewmembers to practice some of the AFT inflight procedures (e.g.,
donning/doffing of flight hardware) in a micro-g environment.
Flight Hardware Modifications- The most significant modification of future
flight hardware, recommended by both the crewmembers and the investigators, is to
reduce the instrument's size. A smaller instrument package will serve two purposes:
(I) it can be worn on the body during launch, which would eliminate data loss on the
critical mission day O; and (2) the size reduction will facilitate crew mobility and
comfort at critical activity periods during the mission. The feedback displays will
also be reduced in size and will function more reliably than the previous flight
hardware. A data playback system will be made available for use by the investigators
before the start of preflight training activities.
Inflight Procedure Changes- Physiological monitoring requirments have been
reduced to include only the first three mission days. Preliminary findings indicate
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that SASis most likely to occur during this time. Further, the proposed hardware
modification described previously should eliminate the requirement for crewmembers
to change cassette data tapes in the middle of a mission day.
Status of Future Flights
Whenfabrication of the flight hardware is complete, this experiment may be
repeated on any future NASAShuttle flight as deemedappropriate by mission
management.
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APPENDIXA:
PREFLIGHTDATAOF BACKUPCREWMEMBERS
Resting Baseline
Table A-I is a summaryof the preflight, resting baseline data for each crew-
member.Meansand standard deviations (SDs) were computedfor each physiological
variable from 60, which were collected during two 30-min sessions, at an average of
I/min.
TABLEA-I.- RESTINGBASELINEDATAMEANSANDSTANDARDDEVIATIONSOF EACH
PHYSIOLOGICALRESPONSE
Crewmember
Finger pulse Respiration Heart Basal skin Finger
volume, rate, rate, resistance, temperature,
units/min breaths/min beats/min log kohm °F
E 13.6 15.3 63.0 4.491 88.2 Mean
5.7 3.9 1.O 0.002 0.9 SD
F 4.1 14.O 62.9 4.790 78.0 Mean
2.8 2.7 1.0 0.073 1.O SD
Baseline Motion Sickness Test
The physiological data of each crewmember recorded during his/her initial
rotating-chair test are shown in figures A-I and A-2. The four physiological varia-
bles selected for plotting were similar to those measured subsequently inflight with
two exceptions. Skin conductance level, the reciprocal of BSR, is plotted and hand
temperature has been substituted for finger pulse volume. The latter substitutions
were necessary because the transducers, and/or electronics of the AFS were not
functional at the time of these data collection sessions.
The X-axes on these graphs were divided into three segments: Baseline, minutes
I through 10 which preceded the start of rotation; Test Minutes, the time during
actual rotation which varied for each subject; and Baseline, 10 min immediately
following the end of chair rotation.
Autonomic Conditioning/Testing
Crewmember E- Figure A-3 shows the number of rotations tolerated by Crew-
member E during all preflight rotating chair tests. Figure A-4 is a z-score graph of
the physiological data collected during rotating chair tests before and after AFT.
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Figure A-3.- Motion sickness tolerance before, during and after training:
Crewmember E.
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This subject's susceptibility to motion sickness wasmoderate to low prior to train-
ing. Although he was highly motivated, his improvement in motion sickness tolerance
following AFTwas not as large as anticipated by the investigators for a "low sus-
ceptible" subject. This_resul_ may_havebeen due _to changes°in the planned training
schedule. Figure A-5 shows malaise levels reported before and after training.
Crewmember F- Changes in motion sickness tolerance for Crewmember F across all
preflight rotating-chair tests are shown in figure A-6. For this crewmember we have
provided two sets of data; the first compares the pretraining rotating-chair test to
a test administered after 4 hr of training (figs. A-7 and A-8). The second set
compares pretraining data with the final rotating-chair test when training was
complete (figs. A-9 and A-IO). On the day of the final test, this crewmember was
suffering from gastrointestinal flu (diarrhea) but decided to proceed.
The first set of graphs (figs. A-7 and A-8) show the degree of control of this
crewmember after 4 hr of training. The crewmember's heart rate was more stable after
4 hr of training than before. It is unlikely that the heart rate was influenced
significantly by breathing since there is very little difference in respiration rate
for the two tests.
During the posttraining test (figs. A-9 and A-IO), it was immediately apparent
that this subject showed less control of physiological responses than in the previ-
ous test. The bar graph of the diagnostic points suggests that as control of physi-
ology began to decline, more malaise was experienced.
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Figure A-5.- Malaise levels before and after training: Crewmember E.
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Figure A-8.- Malaise levels during tests I and 3: Crewmember F.
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Figure A-tO.- Malaise levels during tests I and 4: Crewmember F.
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APPENDIX B:
AFT
3AFT23
PAYLOAD FLIGHT DATA FILE BOOK (PFDFB)
PFDFB is a manual prepared by Marshall Space Flight Center (MSFC)
used by crewmembers during the mission. It contains instructions
for performing the experiment.
PRECEDING PAGE BLANK NOT FILMED
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GENERAL INFORMATION
The Autogenic Feedback Training Experiment is designed to assist Shuttle crewmembers
in countering the effects of Zero-Gravity Motion Sickness by the use of autogenic
feedback methods. The experiment is separated into two major activities: An exten-
sive preflight training activity and self-practice sessions, and the in-flight
autogenic feedback activity performed both in timeline practice and symptom contin-
gent modes. In addition, instrumentation will be attached to crewmembers for con-
tinuous monitoring of four (4) physiological parameters and acceleration.
Instrumentation for the AFT experiment will consist of electrodes attached to the
crewman, a wire harness transmitting the signals from the transducers to the elec-
tronics system, a mesh undergarment used both for transducer placement and harness
attachment, a belt to hold the electronics system, and a self-contained electronics
system. The Autogenic Feedback System (AFS) consists of two (2) units: An analog
signal conditioning front-end/cassette data tape recorder unit and a wristwatch
feedback display.
EO-2 AFT/SL-3/FIN A
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WHITE ECG
GREEN ECG
CABLE-TABS
RESPIRATION
TRANSDUCERS
CHEST
WHITE
BLACK
,BLACK ECG
SEE EO-5
FOR DETAILS
(CABLE HARNESS)
,/II
ABDOMEN
FEEDBACK
DISPLAY
BVP & TEMP.
TRANSDUCERS
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/BSR ELECTRODES
BVP AND TEMP.
CABLE LEAD
FEEDBACK
DISPLAY CABLE
BSR CABLE LEADS
LEAD SHOULD
BE ON OUTSIDE
OF FINGER
\
.... BSR CABLE LEADS
..... BVP AND TEMP.
CABLE LEAD
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VERY LIGHTWEIGHT HEADSET
TRI-AXIAL ACCELEROMETER
PORTABLE INTERCOM
CABLE RETAIN
CLAMP
BODY HARNESS
CABLE HOLE
/
J3
J1
J2
AFS AND RECORDER
EO-6 AFT/SL-3/FIN A
86
CHECKLIST
CL-I AFT/SL-3/FIN A
87
AFT CHECKLIST
Identical activities take place the first 5 days of the mission with the exceptions
noted.
MET day O: The equipment is donned prior to launch with the exception of the
headset, which is donned after launch.
MET day 4: The equipment is removed at the end of the day and stowed
Re-entry day: Payload Specialists only -- the equipment is donned and AFS
unit mounted under the seat
Upon arising on MET days I and 3, change batteries (Procedure 6), don equipment
(Procedure I), and activate AFS unit (Procedure 2). On MET day 2, don
equipment and activate AFS unit.
2 Perform diagnostic scale (Procedure 3).
3 SUBJECTS ONLY - Perform preventative session (Procedure 4).
Record continuously the physiological responses on each crewmember's cassette
tape recorder for 7.5 hours during normal activities.
5 Change tape cassette (Procedure 5).
6 Perform diagnostic scale (Procedure 3).
Continuously record activities for additional 7.5 hours. When tape is full,
deactivate electronics.
8 Upon retiring each day, remove and stow both used tapes and equipment
(Procedure 9).
NOTE
Should symptoms of Space Adaptation Syndrome appear, the subject crewmembers
should perform Procedure 8. The control crewmembers should perform
Procedure 3.
EXERCISE #I:
EXERCISE #2:
EXERCISE #3:
EXERCISE #4:
EXERCISE #5:
EXERCISE #6:
MUSCLE
WARMTH
CARDIAC
RESPIRATION
ABDOMEN
FOREHEAD
AUTOGENIC EXERCISES
CL-2 AFT/SL-3/FIN A
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I - AFS EQUIPMENT PLACEMENT AND CONNECTION
INITIAL CONDITIONS CREW NOTES
MF71M
Verify electrodes are securely
attached to body
*If not, *
* perform ELECTRODE REPLACEMENT *
* (PROCEDURE-7, pg. NOM-IO) *
Open stowage locker
Unstow garment
Don garment, centering holes over
electrodes
Unstow respiration transducers and
snap on garment
6 Unstow cable harness
7 Unstow BVP ring and attach cable
connector to harness
8 Extend harness up body and down left
arm
9 Retain harness by fastening Velcro
clamps around cables
10 Feed BSR and BVP cables through
hole on left sleeve
11 Snap cable ECG leads onto
correct body electrodes
12 Connect harness to respiration
transducers
13 Snap cable leads to BSR electrodes
14 Place BVP ring on finger and
secure with tape
15 Close zipper on left sleeve
NOM-2
Connectors should face
each other on the left
side of body
Green lead - left shoulder
White lead - right shoulder
Black lead - left side
Chest transducer mates to
white harness connector.
Abdomen transducer mates
to black harness connector
AFT/SL-3/FIN A
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I - AFSEQUIPMENTPLACEMENTANDCONNECTION
INITIAL CONDITIONS CREW NOTES
16 Unstow and don outer garment
17 Bring harness connectors out through
hole in outer garment
18 Unstow display unit and secure display
Velcro band around wrist
19 Connect display to harness and restrain
display cable with Velcro on
left sleeve
20 Unstow belt and pouch containing AFS unit
21 Unstow cassette tapes (two)
Place cassette 'B' in pouch pocket
23 Connect harness to AFS connector No. J1
and J2
24 Unstow log book and place in belt
pouch or in pocket of outer garment
25 Close stowage locker
26 Remove Lightweight Headset from
stowage and place on head
27 Connect accelerometer cable (tied to
headset cable) to AFS
connector No. J3
28 Proceed to AFS ACTIVATION (PROCEDURE-2,
pg. NOM-4)
Cassettes are labeled by
mission day.
NOM-3 AFT/SL-3/FIN A
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2 - AFSACTIVATION
INITIAL CONDITIONS CREW NOTES
AFS POWER sw - ON
Wrist display reads:
AFS
CREW ID = O VI.4
Push INC or DEC keys to set assigned
crew i.d. number
Push MODE key once
Wrist display reads:
Tape ID = OA
Push INC or DEC keys to set tape i.d.
Push MODE key once
Wrist display reads:
SUBJECTS CONTROLS
HR=60* BVP=500 HR= * BVP=
RR=12 BSR=500 RR= BSR=
Verify that no errors appear on the
display
* If 'HI', 'LO', '0' appears in data *
* fields, OR if 'X', 'Y', 'Z', or 'T' *
* appears before the BSR field, *
* Go to MAL procedures *
Push MODE key once
/'*' disappears
NOTE
Transient errors may occur at this time.
If error remains displayed for more than
I minute, go to MAL procedures.
Record MET in DIAGNOSTIC SCALE log book
Go to SELF-ADMINISTERED DIAGNOSTIC SCALE
(PROCEDURE-3, pg. NOM-5)
NOTE: VI.4 refers to
the software version in
use. Crewmembers should
ignore.
INC : Increment
DEC : Decrement
MS-I ID=2
MS-3 ID=4
PS-F ID=3
PS-M ID=5
The first digit refers
to MET day: 0-9; the
second digit refers to
first or second tape of
the day: A or B,
respectively
Now in EQUIPMENT
CHECKOUT Mode
The numbers shown on the
SUBJECT display are
typical values. The
data fields on the CON-
TROL display will be
blank unless there is
an error message
Now in DATA COLLECTION
Mode
NOM-4 AFT/SL-3/FIN A
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3 - SELF-ADMINISTERED DIAGNOSTIC SCALE
INITIAL CONDITIONS CREW NOTES
............ SYMPTOM CONTINGENT OPS ................
• I Push EXEC key twice Marks the start o£
Display will blink off, then on again the procedure on tape
2 Note in log book:
ID number and on relative rating
scales, cheek off the level of each
class ot symptom indicating your
present condition and any pertinent
commentary
............ SYMPTOM CONTINGENT OPS ................
3 Push EXEC key twice Indicates end of
SUBJECTS CONTROLS procedure
HR=60* BVP=500 HR= * BVP:
RR=12 BSR:500 RR= BSR=
.............................. , o • . . ....
(;REIPMIEMaE R __
SUMMARY OF DIAGNOSTIC SCALE
_MI$SION DAY TIME__
DIAGNOSTIC CRITE RIA ._A LE -- SPACE ADAPTATION SVNOROME
MALAISE LEVEL POfNTS VMT TMP DIZ HA(; ORZ SWT PAL SAL NSA EO EA
PATHOGNOMIC IS I
MA,JOR II I1! III III III It,Ill
MINOR 4 II I! II II I
MINIMAL 2 I I I I I
AOS I I.II I.II I I
This section is a shorthand
ducription of the criteria
used in assigning levels of
malaise
LEVELS OF SEVERITY IDENTIFIED BY TOTAL POINTS SCORED
PRANK II(;KNEU SEVERE MALAISE MODERATE A MODERATE S SLIGHT MALAISE
(S) [Mill) (MIIA| (MIIR| (MI|
1s POINTS l-iS POINTS E-7 POINTS 3*4 POINTS I-Z POINTS
TIME- SYMP SYMPTO_IS ELSE RVEO TOTAL
L_NEO (;ONT. VMT TMP DIS MAC ORZ SWT PAL SAL NSA EO EA POINT_;
I I I I
COMMENTS:
* Boa I or 2 -
Box 3 'VHT' -
Box II 'THP' *
Box 5 'DIZ* -
BOX 6 'HAt' *
BE= 7 'DRZ' -
Iloz 8 '$1_i" -
BO_ 9 'PAL' -
BOX I0 *$AL' -
Bol I1 'PSi' -
Box 12 'ED' -
Box 13 'rE' -
This section is the working
section to be used for two
events per sheet
Should be chocked tO determine whether the •elsiE. II tlmellned
ictlvity or • lympt_ eontlngent one
VOMITING ta not differentiated with raapect Ix} level, if r1_pt(m Is
obsRrved, raeord 'I'
INCREASED 800¥ TEMP Is reported in t_ levels. Record 'I" tar mild-
to*modarate or 'IS* for Imllarmta°to-savere
DIZZINE33/VERTIGO is reported in two IRvela. Record 'i' for mlld°
to-mxlarata Or 'IS' for llodereta-to-aavere
HEADACHE Ls reported to two levelS. Rsoord 'I' for elld*to-moderete
or 'IS' for modRrsta-to-aarva
DRO_SIN_ is reported as 'I' - mild, 'IS' - moderate, or '[11' -
lavera
SI_ATING ia reported a= 'I' -mlld, 'IS* - moderate, or 'Ill' *
sevlre
FkCIAL PALLOR Is reported ms 'I' -mlld, 'II' - moderate, or 'Ill' -
severe
INCR[ILSED SALIVATION is reported am '|' - mild, 'IS' ° mmdeMlta, or
'Ill' - severe
NAUSEA |s reported as 'I' - mild, 'IS' ° moderate, or 'SIS' - severe
[P[GASTR[C DISCOMFORT describes the S_mp_mu am not naus_, hut
|here|sad Sensations l_ the Itoeeeh, It [a not oonaiderl_l
une_fortab|e (e.g., pressure Or _11neaa In Stl_aeh). Re_rd '|'
tf this 3ymptom Ls present
EPIGA._TR[C AWARENF._ daaeribea the S)nmptoes as l_Ot rumsel, but
becoltng uncomCortable (e.g., lump in throat, knot te atmmeh).
Record '[' If this symptom Is present
NOM-5 AFT/SL-3/FIN A
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4 - PREVENTIVE AFT EXERCISE SESSION
INITIAL CONDITIONS
Only the SUBJECT group crewmembers
are required to perform this procedure
CREW NOTES
3
4
NOTE
AFT EXERCISE SESSION should be
performed in an area providing
minimal distractions
Secure self in a stationary
position such that no muscle
tension is needed to maintain
posture
Push EXEC key twice
Display will blink off, then on
again
Using display unit,
Regulate autonomic reponse
levels in manner pre-
scribed during preflight
training
At end of session,
Push EXEC key twice
Strap into bunk if possible
Marks start of
procedure
Marks end of procedure
NOM-6 AFT/SL-3/FIN A
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5 - CASSETTE TAPE CHANGEOUT
INITIAL CONDITIONS
Make sure display is connected to cable
harness before proceeding with tape
changeout.
CREW NOTES
I Push MODE key
Display reads:
CHANGE TAPE?
MODE = YES
2 Push MODE key
Display reads:
TAPE ID = XX
3 Open pouch flap
4 Lift AFS access cover
5 Rotate head lever ccw to
retract heads
6 Remove 'used' tape,
Temporarily tuck in belt
7 Remove 'new' tape from
pocket on AFS pouch
and install in AFS
8 Rotate head lever cw to
reposition heads
9 Close AFS access cover
Close pouch flap
Stow 'used' tape in pocket
on AFS pouch
Reactivate AFS (PROCEDURE-2,
pg. NOM-4, step 4)
10
11
12
Tape has now stopped
Display will show the last
tape ID entered
NOM-7 AFT/SL-3/FIN A
95
6 - BATTERYREPLACEMENT
INITIAL CONDITIONS CREW NOTES
MF71M
10
11
12
13
Open stowage locker
Obtain AFS
/AFS POWER sw - OFF
Remove AFS from belt pouch
Unscrew battery retaining
screws (four)
Remove battery pack from AFS and
disconnect cable
Unstow new battery and stow
expended battery in vacant
slot in locker
Remove new battery from sealed bag
Discard bag in S/L trash
NOTE
When installing battery,
writing on connector
should be showing
Connect battery cable and insert
fresh battery pack into AFS
Tighten battery retaining
screws (four)
Replace AFS in belt pouch and
temporarily restow in stowage
locker
Proceed to AFS EQUIPMENT PLACEMENT
AND CONNECTION (PROCEDURE-I,
pg. NOM-2)
NOM-8 AFT/SL-3/FIN A
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7 - ELECTRODE REPLACEMENT
INITIAL CONDITIONS CREW NOTES
Remove loose electrode(s) and
discard in S/L trash
2 Open AFT stowage locker
Unstow packet of DIAGNOSTIC ECG
ELECTRODES used for BSR or
QUICK PREP ECG electrodes and
alcohol wipes
4 Slide card of electrodes from
packet
5 Remove electrode from card
6 Place on desired location
7 Restow packet of electrodes
8 Close AFT stowage locker
BSR ELECTRODES STWG - MF710
ECG ELECTRODES STWG - MF71M
Use alcohol wipes to
clean skin before
replacing ECG electrodes.
DO NOT clean skin on
wrist before replacing
BSR electrodes.
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8 - SYMPTOMCONTINGENTCOUNTERACTIVEAFTSESSIONS
INITIAL CONDITIONS
Only the SUBJECT group crewmembers are
required to perform this procedure
CREW NOTES
NOTE
SYMPTOM CONTINGENT COUNTERACTIVE
AFT SESSIONS should be performed
(if possible) in an area providing
minimal distractions
Secure self in a stationary
position such that nomuscle
tension is required to maintain
posture
Perform SELF-ADMINISTERED DIAGNOSTIC
SCALE (PROCEDURE-3, pg. NOM-5)
Using display unit,
Regulate autonomic response levels
in manner prescribed during
preflight training
After 30 minutes or at cessation of
symptoms (whichever occurs first),
Perform a second SELF-ADMINISTERED
DIAGNOSTIC SCALE (PROCEDURE-3,
pg. NOM-5)
If necessary, this session
can be performed while
mission ops activity is in
progress
NOM-IO AFT/SL-3/FIN A
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9 - AFS EQUIPMENT REMOVAL AND STOWAGE
INITIAL CONDITIONS CREW NOTES
MF71M
I AFS POWER sw - OFF
2 Open stowage locker
3 Open cassette pocket on the
pouchand remove used tape
4 Stow cassette tape in sequence
5 Disconnect AFS from harness and
accelerometer
6 Remove and stow Lightweight Headset
according to usual procedures
7 Remove belt/pouch with AFS from
body
8 Open pouch flap
9 Lift AFS access cover
10 Remove cassette tape
11 Stow cassette tape in sequence
12 Rotate head lever ccw to retract heads
13 Insert cassette 'A' for next day
14 Rotate head lever cw to reposition
heads
15 Close access cover
16 close pouch flap
17 Fold and stow belt with pouch
containing AFS in stowage locker
18 Unfasten wrist display unit
Fold and stow display unit
19 Remove outer garment and secure
20 Remove BVP transducer from finger
21 Disconnect BVP transducer from harness
and stow
NOM-11 AFT/SL-3/FIN A
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9 - AFS EQUIPMENT REMOVAL AND STOWAGE
INITIAL CONDITIONS CREW NOTES
22 Disconnect harness from remaining
transducers and electrodes
23 Unfasten Velcro harness retainers
24 Remove harness
25 Fold and stow harness
26 Unsnap and stow respiration transducers
27 Remove, fold, and stow garment
28 Close stowage locker
NOM-12 AFT/SL-3/FIN A
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ATTEMPT TO L._
REMOVE TAPE I
FROM UNIT J
WAS TAPE _-_ NO
SUCCESSFULLY
REMOVED? /
YES
MANUALLY L_
REWIND LOOSE I
TAPE AND STOW I
16
• STOW MALFUNCTIONING
AFS UNIT
• USE SPARE AFS UNIT
(STWG - MF71M)
CONSULTPOCC TO
SCHEDULE BATTERY
CHANGEOUT
•o_ow._.._._._
_c_ |
:,_,_F_O_,_I
L_
GO TO AFS ACTIVATE |
PROCEDURE (PG. NOM-5) I
/
AND REACTIVATE UNIT I
USING TAPE ID OF l
JAMMED TAPE /
MAL-I AFT/SL-3/FIN A
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I • RESTRAIN MOTION _ RETURN TO
• _/ DISPLAY FOR NOMINAL OPS
ERRO
YES
2' ELECTRODES AND HARNESS_-_
• _'ACTUAL PULSE RATEL_ V _
• IS PULSE WITHIN I J FOR LOOSE CONNECTION J
I I
RANGE 40 TO 1807 . J [
YES
NO
l
RETURN ToL_
NOMINAL |
OPS /
171
• REPLACE ELECTRODES L--. I
(STWG - MF71M) |• _/DISPLAY FOR ERROR
• SUBSTITUTESPAREHARNE
(STWG - MF71M) /
• _/DISPLAY FOR ERROR l
IA
• STOW MALFUNCTIONING _-
AFS UNIT
• USE SPARE AFS UNIT
(STWG-MF710)
CONSULT POCC TO
SCHEDULE BATTERY
CHANGEOUT
NO
NO
MAL-2 AFT/SL-3/FIN A
102
BSR = HI OR LO
SYMPTOM: BSR SIGNAL RECOGNIZED AS INCORRECT
CREW RESPONSE:
REMOVE SNAP FROM I_
ONE BSR ELECTRODE /DISPLAY LO OR HI ?
REPLACE BATFERY
(STWG-MF71 M)
•# DISPLAY FOR ERROR
BSR DISPLAY L_1
ERROR
HI OR LO ?
LO I HI
HI
y
LO
-- i'VER' SSRELEC O0  SNAP CONNECTIONSARE SECURE
• _ DISPLAY FOR ERROR
• REPLACE ELECTRODES L__._
(STWG-MF71 M)
• J DISPLAY FOR ERROR
_ YES
• SUBSTITUTE SPARE "^'11_._
HARNESS (STWG-MF71 M)
• J DISPLAY FOR ERROR
I_ YES
IAI
• SUBSTITUTE SPARE
HARNESS (STWG-M71 M) /• _ DISPLAY FOR ERROR
RETURN TO
NOMINAL OPS
't
• REVERSE ELECTRODE 6_
SNAPS /• J DISPLAY FOR ERROR
CONSULT POCC TO I_
SCHEDULE PERFORMANCE I
OF IFM PROCEDURE /
(PG. IFM-2) |
• STOW MALFUNCTIONING _11
AFS UNIT
• USE SPARE AFS UNIT
(STWG-MF710)
CONSULT POCC TO
SCHEDULE BATTERY
CHANGEOUT
YES
RETURN TO
NOMINAL OPS
MAL-3 AFT/SL-3/FIN A
lO3
"RESTRANMOTON'EL] I
ANDBREATHNORMALLYI___
• _D,SPLAYFORERRORI l RETURN TO L__NOMINAL OPS
CHEST TRANSDUCER
AND HARNESS FOR /LOOSE CONNECTION
I ,JDISPLAY FOR ERROR [--_ NO
1
CHEST I NO I TOTRANSDUCER_ NOMNAL
• _DISPLAYFORERRORI I OPS
YES
I I
• REPLACE TRANSDUCERS L_
(STWG-MF71M) !• _v/ DISPLAY FOR ERROR
YES
I=1
• SUBSTITUTE SPARE I_
HARNESS (STWG-MF71M} r• _/DISPLAY FOR ERROR
YES
L
• STOW MALFUNCTIONING AFS
UNIT
• USE SPARE AFS UNIT
[STWG - MF710)
NO
NO
CONSULT POCC TO SCHEDULE
BATTERY CHANGEOUT
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GO TO
HR MAL
PG MAL2
I I
• RESTRAIN MOTION AND I = I
HOLD LEFT HAND AND
FINGER STILL
• DISPLAY FOR ERROR
lNO
IS MR ERROR PRESENT_
JALSO?
YES
• REPOSITION TRANSDUCER_ NO
ON FINGER /
• /DISPLAY FOR ERROR /
/
S YES
I I
• VERIFY BVP CONNECTION
CABLE HARNESS IS SECURE I
/
• / DISPLAY FOR ERROR /
YES
• REPLACE TRANSDUCER I 5 I
(STWG - MF71M} L_ NO• _ DISPLAY FOR ERROR
YES
I • SUBSTTUTESPARE _--_
HARNESS (ST WG MF71M) _ NO
• _ DISPLAY FOR ERROR J
YES
k
• STOW MALFUNCTIONING AFS
UNIT
• USE SPARE AFS UNIT
(STWG MF71M)
CONSULT POCC TO SCHEDULE
BATTERY CHANGEOUT
RETURN TO NOMINAL_OPS
HAL-5 AFT/SL-3/FIN A
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• _ VIEWING ANGLE OF DISPLA NO
• DISPLAY FUNCTIONING ?
YES
RETURN TO NOMINAL OPS
t .
• _/AFS POWER
IS ON
• _/DISPLAY FOR LOOSE
CONNECTIONS AT
WRIST AND AT UNIT
(DO NOT DEMATE)
• DISPLAY FUNCTIONING ?
J YES
NO
m
• PUSH VIEW KEY
UP TO 8 TIMES
• DISPLAY FUNCTIONING ?
I YES
• RECYCLE AFS
POWER SWITCH
• DISPLAY FUNCTIONING ?
YES
GO TO AFS
ACTIVATION
(PG. NOM-5)
L_ 7
• STOW DISPLAY _-_
1
• USE SPARE DISPLAY l NO
_STWG-MFT,M_I---
• _/DISPLAY L
FUNCTIONING ? J
RETURN TO NOMINAL
OPS
I REPLACE BATTERyL'_ NO
PACK (STWG-MF71M)
DISPLAY
FUNCTIONING ?
YES
RETURN TO NOMIN
OPS ALJ
• SUBSTITUTE L_
SPARE HARNESS (STWG - MF71M) I
• DISPLAY FUNCTIONING ? r
J YES l NO
• STOW MALFUNCTIONING
AFS UNIT AND DISPLAY
• USE SPARE AFS UNIT
AND DISPLAY (STWG - MF71M)
CONSULTPOCC TO
SCHEDULEBATTERY
CHANGEOUT
MAL-6 AFT/SL-3/FIH A
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BSR DISPLAY ___
READING
= LO
• UNSTOW MULTIMETER I 2
/
(STWG IN L2E/5)
• TAKE READING OF
SKIN RESISTANCE
AT TIP OF BSR
ELECTRODE
• RECORD READING IN
LOG BOOK
• RESTOW MULTIMETER
1
WAS METER READING
30K ?
S YES
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RETURN TO NOMINAL oPsL_
/
½
• STOW MALFUNCTIONING
AFS UNIT
• USE SPARE AFS UNIT
(STWG - MF71M)
CONSULTPOCCTO
SCHEDULE BATTERY
CHANGEOUT
MAL-7 AFT/SL-3/FIN A
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DISPLAY READS I 1 1 NOXBSR, YBSR, OR ZBSR ?
YES
I.I
• PRESS INC BUTTON ON L_ ,..,..
WRIST DISPLAY UNIT
• _ DISPLAY FOR ERROR
YES
ACCELERQMETER
MALFUNCTIONING,
• STOW MALFUNCTIONING
ACCELEROMETER HEADSET
• UNSTOW AND DON SPARE
ACCELEROMETER HEADSET
(STWG - MF71M}
1
RETURN TO NOMINAL
OPS
DISPLAY READS TBSR
v / CONNECTION OFRING TRANSDUCER
.  REssNCBOTTO.WRIST DISPLAY UNIT _ NO
• _/DISPLAY FOR ERROR I
YES
TURE < 21 C ?
NO
REPLACE FINGER _-_
TRANSDUCER (STWG-MF71M) J
I
i l
• PRESSINC BUTTON I 10 t
ON WRIST
DISPLAY
I
I __ I
RETURN TO NOMINAL
OPS _"=P"""
HALo8 AFT/SL-3/FIN A
I08
IN-FLIGHT MAINTENANCE
NOTE:
APPROVAL TO PERFORM IFM PROCEDURES AND THE
SCHEDULING OF THE IFM PERFORMANCE MUST BE
RECEIVED FROM POCC/MCC PRIOR TO PROCEEDING
IFM-I AFT/SL-3/FIN A
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I
I I
REMOVE SNAP FROM J 2 I
ONE BSR ELECGRODE
DISPLAY LO OR HI ?
BSR DISPLAY
ERROR
HI OR LO ?
LO I HI
HI
REPLACE BATTERY L_
(STWG - MF 71M)
_' DISPLAY FOR ERROR
HARNESSCSTWG- MF71MI
v * _/DISPLAYFOR /
ERROR /
RETURN TO
NOMINAL OPS
• REVERSE
ELECTRODE SNAPS
• _/DISPLAY FOR
ER OR
j.o
I-,I
CONSULT POCC TO I_
SCHEDULE PERFORMANCE J
/
OF IFM PROCEDURE J
(PG. IFM-21 ]
• VERIFY BSR ELECTRODEJ 8
SNAP CONNECTIONS
ARE SECURE
LO • _/DISPLAY FOR
ERROR
1
NO
j • REPLACE _-_ N ^
ELECTRODES (STWG-MF71M)
• _ DISPLAY FOR ERROR
• SUBSTITUTE 1_
SPARE HARNESS
(STWG - MF71M)
• _/DISPLAY FOR
ERROR
YES
• STOW MALFUNC-
TIONING AFS UNIT
• USE SPARE AFS UNIT
(STWG - MF710)
CONSULT POCC TO
SCHEDULE BATTERY
CHANGEOUT
RETURN TO
NOMINAL OPS
IFM-2 AFT/SL-3/FIN A
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APPENDIXC
PROCEDURESFORSELF-ADMINISTERINGDIAGNOSTICSCALEINFLIGHT
Note: This procedure is identical for time-lined and symptom-contingent sessions.
I. Crewmemberremoves diagnostic booklet (3" X 5" spiral notepad) and pencil from
pocket and opens to a blank page. Each page in this diagnostic booklet will be
printed as follows:
MISSION
CREWMEMBER DAY TIME
DIAGNOSTICRITERIASCALE- SPACEADAPTATIONSYNDROME
MALAISELEVELPOINTS VMT TMP DIZ HAC DRZ SWT PAL SAL NSA ED EA
PATHOGNOMIC16 I
MAJOR 8 III III III III II,III
MINOR 4 II II II II I
MINIMAL 2 I I I I I
AQS I I II,II I,II
Levels of Severity Identified by Total Points Scored
FRANKSICKNESS SEVEREMALAISE MODERATE-AMODERATE-BSLIGHTMALAISE
(S) (MIII) (MIIA) (MIIB) (MI)
16 points 8-15 points 5-7 points 3-4 points I-2 points
TIME-
LINED
COMMENTS:
SYMP
CONT.
SYMPTOMSOBSERVED TOTAL
VMT TMP DIZ HAC DRZ SWT PAL SAL NSA ED EA POINTS
I I I I I I I I I I I
......i ...I....I....I....I....I....I....I....I....I....I....I
I i i I I i I i I I I
....i....I....I....i....I....I....I....I....i....i....i
2. Before writing on diagnostic sheet, push event button on ambulatory monitoring
package to indicate start of session.
3. Indicate type of session by checking box maked "TIME-LINED" or "SYMP CONT."
(symptom contingent). There are two rows provided on each page for those sessions
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requiring that diagnostic be performed twice (i.e., before and after symptom
contingent AFTsessions).
4. If vomiting has o_cured, print the letter_"I" in the box marked "VMT".
5. Very minor symptomsof motion sickness are listed in this diagnostic scale as
"AQS"- Also Qualifying Symptoms.Included in this symptomcategory are:
a. Increased body temperature - "TMP"
b. Dizziness/vertigo - "DIZ"
c. Headache- "HAC"
The subject has the option of reporting two levels of increased temperature and
dizziness (mild-moderate "I" or moderate-severe "If"). Level of headacheis not
differentiated. If ANYdegree of headache is experienced, the subject prints the
letter "I" in the box marked "HAC".
6. Remaining symptomsof motion sickness (not including Nausea) are :
a. Drowsiness -
b. Sweating -
c. Facial Pallor -
d. Increased Salivation -
"DRZ"
"SWT"
"PAL"
"SAL"
Each of these symptomscan be described as mild, moderate or severe by writing in
the appropriately marked box, "I" , "II" or "Ill", respectively. Note: The degree a
facial pallor can be assessed by providing the crewmemberwith a "mirror" (plastic),
glued to the back cover of the diagnostic booklet.
7. Symptomsof nausea or any sensations associated with the "gut" can be reported as
five separate levels.
a. Epigastric Awareness - "EA"
This is described as increased sensations for the stomach but not considered
uncomfortable. Reported by marking "I" in the box beneath "EA".
b. Epigastric Discomfort - "ED"
This is described as NOTnausea, but becoming uncomfortable (e.g., lump in
throat, knot in stomach). Reported by marking "I" in the box beneath "ED".
c. Nausea - "NSA"
Reported as mild , moderate or severe by entering "I"
respectively.
, "If" or "III",
8. Entering point values in the box marked "TOTALPOINTS"can be done if crewmember
wishes but is not critical for this inflight procedure (can be done post-flight).
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An example of a diagnostic report of a crewmemberwho experiences an increase in
body temperature, somedizziness, moderate sweating and mild nausea is printed
below:
CRETAN DATE TIME
DIAGNOSTICRITERIASCALE- MOTIONSICKNESSTEST
MALAISELEVELPOINTS VMT TMP DIZ HAC DRZ SWT PAL SAL NSA ED EA
PATHOGNOMIC16 I
MAJOR 8 III III III Ill II,lll
MINOR 4 II II II II I
MINIMAL 2 I I I I I
AQS 1 I II,II I,II
Levels of Severity Identified by Total Points Scored
FRANK SICKNESS SEVERE MALAISE MODERATE-A MODERATE-B SLIGHT MALAISE
(S) (MIII) (MIIA) (MIIB) (MI)
16 points 8-15 points 5-7 points 3-4 points I-2 points
TIME- SYMP
LINED CONT.
X
COMMENTS:
SYMPTOMS OBSERVED TOTAL
VMT TMP DIZ HAC DRZ SWT PAL SAL NSA ED EA POINTS
II il i I fill I I li I I
.... I.... i.... I.... i.... l.... I.... I.... i.... i.... I.... i
I I I I I I I I i I I
.... i.... i.... I.... i.... i.... I.... I.... I.... I.... i.... i
10
By referring to the KEY listed on the top of the pge, it can be seen that the
symptoms of:
and
"increased temperature" : I
"some dizziness" : I
"moderate sweating" = 4
"mild nausea" = 4
diagnostic point;
diagnostic point;
diagnostic points;
diagnostic points.
TOTAL POINTS = 10
The experimenters would rate this subject as having experienced "SEVERE MALAISE" or
Malaise Level III (MIII).
9. COMMENTS: Because this is a subjective scale, a COMMENT section has been
provided at the bottom of each diagnostic sheet so that the crewman may qualify his
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report if he wishes. For example, the crewman may experience severe headache and
this is his only symptom. Although the report of headache would result in TOTAL
POINTS = I (or SLIGHT MALAISE), the crewmember may wish to indicate in the COMMENT
section that the headache he is experiencing is severe (i.e., "This feels like a bad
sinus headache" or "This feels like a migraine headache"). The COMMENT section
might also be used by the subject to offer his personal evaluation of the
effectiveness of the treatment. (e.g. "After the practice AFT session, I felt
better"; or "I don't really notice any difference in symptoms after treatment").
Consequently, the information entered in the COMMENT section may be very useful for
evaluating the effectiveness of AFT as a treatment and for elucidating descriptions
of the nature of Space Adaptation Syndrome.
10. End of session ° Crewmember presses the event button on his ambulatory
monitoring package and replaces diagnostic booklet and pencil in pocket.
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